Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVidendum Plc Regulatory News (VID)

Share Price Information for Videndum Plc (VID)

Share Price is delayed by 15 minutes
Get Live Data
377.50    -14.50 (-3.70%)
Bid:
375.00
Ask:
380.00
Spread: 5.00 (1.333%)
Market Cap: £157.95m
VID Live PriceLast checked at - London Stock Exchange

Intraday Videndum Plc Share Chart

2024 Half Year Post-close Statement

11 Jul 2024 07:00

RNS Number : 9471V
Videndum PLC
11 July 2024
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO THE SAME WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

Β 

11 July 2024

Videndum plc

2024 Half Year Post-close Statement

Videndum plc ("the Group" or "the Company"), the international provider of premium branded hardware products and software solutions to the content creation market, issues a post-close statement for the half year ended 30 June 2024.

The Group's first half revenue was broadly in line with its expectations, reflecting some post-strike recovery in the cine and scripted TV market, however the recovery is taking longer than anticipated. Net debt at 30 June 2024 was c.Β£118 million, down from Β£122.4 million at 31 March 2024.Β 

The macroeconomic environment affecting the consumer and independent content creator segments remains challenging, and the Group has maintained its focus on controlling costs, capex and working capital tightly. The Broadcast TV segment continues to perform well, and the Group's second half performance will benefit from the Summer 2024 Olympic Games and the US Presidential election.

The Board continues to expect a recovery in the second half of FY 2024 as the cine and scripted TV market gradually recovers. Although we are seeing signs of improvement, as previously highlighted, the pace and shape of the post-strike recovery remains uncertain.

As expected, the Group has renegotiated its committed Revolving Credit Facility ("RCF") with its lending banks. The facility has been extended, reduced in quantum, and its lending covenants, particularly interest cover, relaxed - see note 1 for details. These amendments to the RCF preclude the Board from declaring a dividend until delivery of the 31 March 2025 covenant test.

Videndum's interim results for the six months ending 30 June 2024 are expected to be released in late September 2024.

Β 

For more information please contact:

Videndum plc

Telephone: 020 8332 4602

Stephen Bird, Group Chief Executive

Andrea Rigamonti, Group Chief Financial Officer

Β 

Notes to Editors:

Videndum is a leading global provider of premium branded hardware products and software solutions to the content creation market. We are organised in three Divisions: Videndum Media Solutions, Videndum Production Solutions and Videndum Creative Solutions.

Videndum's customers include broadcasters, film studios, production and rental companies, photographers, independent content creators ("ICC"), professional musicians and enterprises. Our product portfolio includes camera supports, video transmission systems and monitors, live streaming solutions, smartphone accessories, robotic camera systems, prompters, LED lighting, mobile power, carrying solutions, backgrounds, audio capture, and noise reduction equipment.

We employ around 1,600 people across the world in ten different countries. Videndum plc is listed on the London Stock Exchange, ticker: VID.

More information can be found at: https://videndum.com/

LEI number: 2138007H5DQ4X8YOCF14

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of Videndum plc is Jon Bolton, Group Company Secretary.

Β 

Notes

1

Lending covenants have been amended for June 2024 (leverageΒ² to 4.25x and interest coverΒ³ to 1.5x), September 2024 (interest coverΒ³ to 2.25x), and December 2024 (interest coverΒ³ to 3.0x); interest coverΒ³ to 3.5x thereafter, and quarterly test dates to continue.

Total committed facility has been reduced by Β£50 million to Β£150 million reflecting the lower level of borrowings that the Group is operating with after the equity raise in December 2023. Net debt at 30 June 2024 was c.Β£118 million comprising c.Β£86 million borrowings net of cash and cash equivalents, and c.Β£32 million IFRS 16 lease liabilities.

Termination date has been extended by six months to 14 August 2026.

2

Leverage is calculated as net debt before arrangement fees and after leases of discontinued operations, divided by covenant EBITDA for the applicable 12-month period (being adjusted EBITDA, before share-based payment charges, and after interest on employee benefits, interest related net currency translation gains, and the amortisation of loan arrangement fees); see the Glossary in the Annual Report 2023 for further detail.

3

Interest cover is calculated as covenant EBITA for the applicable 12-month period (being adjusted EBITDA less depreciation of PP&E) divided by adjusted net finance expense (before interest on employee benefits and FX movements, and the amortisation of arrangement fees); see the Glossary in the Annual Report 2023 for further detail.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTMZGMNRGKGDZM
Date   Source Headline
20th May 20269:44 amRNSBlock Listing Six Monthly Return and Cancellation
19th May 20264:20 pmRNSResult of AGM
28th Apr 202610:20 amRNSDirector/PDMR Shareholding
14th Apr 202612:00 pmRNSAnnual Report and Accounts 2025 & 2026 AGM Notice
9th Apr 20261:06 pmRNSTotal Voting Rights
8th Apr 20264:00 pmRNSDirector/PDMR Shareholding - Correction
8th Apr 20261:00 pmRNSDirector/PDMR Shareholding
7th Apr 20262:30 pmRNSDirectorate change
2nd Apr 20268:28 amRNSHolding(s) in Company
1st Apr 20265:38 pmRNSHolding(s) in Company
1st Apr 20264:39 pmRNSHolding(s) in Company
1st Apr 20264:05 pmRNSHolding(s) in Company
1st Apr 20263:37 pmRNSHolding(s) in Company
1st Apr 202610:41 amRNSHolding(s) in Company
1st Apr 202610:40 amRNSHolding(s) in Company
31st Mar 20267:00 amRNS2025 Full Year Results
27th Mar 202611:15 amRNSResults of Capital Raising and General Meeting
25th Mar 20269:41 amRNSDirector Declaration
12th Mar 20265:00 pmRNSHolding(s) in Company
10th Mar 20261:03 pmRNSFirm Placing and Placing and Launch of Open Offer
10th Mar 20261:03 pmRNSFirm Placing and Placing and Launch of Open Offer
10th Mar 202612:04 pmRNSPublication of a Prospectus
10th Mar 202612:04 pmRNSPublication of a Prospectus
10th Mar 20267:00 amRNSComprehensive Refinancing
23rd Dec 20257:00 amRNSUpdate Announcement
23rd Dec 20257:00 amRNSUpdate Announcement
19th Nov 20257:00 amRNSBlock listing Interim Review
16th Oct 20257:00 amRNSUpdate announcement
1st Oct 20257:00 amRNSBoard Changes
1st Oct 20257:00 amRNSNotice of update announcement
3rd Sep 20257:00 amRNSSale of JOBY brand to VIJIM
6th Aug 20257:00 amRNS2025 Half Year Results
29th Jul 20257:00 amRNSBoard Changes
28th Jul 202511:11 amRNSResult of General Meeting
9th Jul 20259:00 amRNSNotice of General Meeting
30th Jun 202512:52 pmRNSHolding(s) in Company
16th Jun 20253:00 pmRNSResults of 2025 AGM
19th May 20258:00 amRNSBlock listing Interim Review
14th May 20251:15 pmRNSChange in Director's details
2nd May 20253:30 pmRNSHolding(s) in Company
2nd May 202511:39 amRNSHolding(s) in Company
2nd May 202510:34 amRNSDirector/PDMR Shareholding
2nd May 202510:30 amRNSHolding(s) in Company
1st May 20255:00 pmRNSHolding(s) in Company
1st May 20259:43 amRNSAnnual Financial Report - CORRECTED DATE OF AGM
30th Apr 20255:30 pmRNSAnnual Financial Report
30th Apr 20257:38 amRNSResult of the Placing
30th Apr 20257:00 amRNSProposed Equity Raise
30th Apr 20257:00 amRNS2024 Full Year Results
22nd Apr 20257:00 amRNSNotice of FY24 Results; Debt financing update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.